Creabilis, a late clinical stage European dermatology company with a focus on pruritus (itch), today announces it has treated the first patients in its Phase 2b study of its lead product, CT327, in patients with atopic dermatitis (AD). The Phase ...
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that detailed results from the Phase 3 VIVID and VISTA trials of EYLEA ® (aflibercept) Injection in Diabetic Macular Edema (DME) will be presented at an oral session during the upcoming ...
Rapid Approval Of Three Minor Amendments; Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing non-toxic DCVax ® personalized immune therapies for solid tumor cancers, announced today that the German regulatory ...
Elcelyx Therapeutics today announced that clinical advisor, John Buse , M.D., Ph.D., will present clinical data for NewMet™, a delayed-release formulation of generic metformin, in an oral presentation at the 49th Annual European Association for the ...
Company to showcase late-stage pipeline, including efficacy, safety and patient-reported health outcomes data for investigational GLP-1 receptor agonist Eli Lilly and Company (NYSE: LLY) today announced that a total of 31 abstracts will be ...
"REGULATE-PCI" to Study REG1 in Patients Undergoing Percutaneous Coronary Intervention Regado Biosciences, Inc. (Nasdaq: RGDO), a biopharmaceutical company focused on the discovery and development of novel, first-in-class, actively controllable ...
REPRISE II Data Honored as Best Abstract 2013 at PCR London Valves Course Boston Scientific Corporation (NYSE: BSX) reported favorable six-month results from the first 60 patients enrolled in the REPRISE II clinical trial evaluating the safety ...
CAMBRIDGE, England , September 17, 2013 /PRNewswire/ -- Acacia Pharma, a pharmaceutical company specialising in the development of drugs for supportive care, announces the initiation of two pivotal Phase 3 studies of APD421 in the ...
SIMPLE Antibody™ with unique mode of action addressing c-Met positive tumors arGEN-X, a clinical stage human monoclonal antibody therapeutics company, announces today the CTA filing of a first-in-man Phase Ib cancer study with ARGX-111, its ...
Atlanta-based pharmaceutical discovery and development company, Celtaxsys, Inc., announced today the achievement of a significant clinical milestone for its lead clinical stage drug candidate, CTX-4430, for treatment of Cystic Fibrosis (CF) lung ...
Bharat Biotech, in collaboration with Biofabri, a Spanish biopharmaceutical firm, is conducting trials for the first live attenuated vaccine MTBVAC ( ) derived from a human strain of Mycobacterium tuberculosis. These trials aim to assess the safety and ...
A multisite clinical trial offers promising outcomes for patients with metastatic and recurrent uterine cancer, also known as endometrial cancer. Presented at the annual meeting of the Society of Gynecologic Oncologists, the study compiled data from ...
Researchers at the University of Oxford in the UK have initiated the first human clinical trial to evaluate ChAdOx1 NipahB vaccine designed to safeguard individuals against the deadly Nipah virus . ( ) ChAdOx1 NipahB Vaccine Trial with 51 Participants to Combat Nipah Virus Threat Fifty-one people aged 18 to 55 will participate in the ...
The stromal processing peptidase (SPP), a chloroplast plant enzyme, reduces the clumping of proteins that cause the pathogenic alterations in models of Huntingtons disease in human cells and the nematode Caenorhabditis elegans ( ). ...
A group of US researchers, who first conducted an ‘ artificial womb ’ experiment in lamb, are now seeking Food and Drug Administration (FDA) approval for its tests on humans ( ). This could potentially reduce deaths and disability for babies ...
Subscribe to our Free Newsletters!
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.
Full Disclaimer
Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2024
Careers